ATE504589T1 - Biologisch aktive macrolide, ihre zusammensetzungen und anwendungen - Google Patents

Biologisch aktive macrolide, ihre zusammensetzungen und anwendungen

Info

Publication number
ATE504589T1
ATE504589T1 AT01959257T AT01959257T ATE504589T1 AT E504589 T1 ATE504589 T1 AT E504589T1 AT 01959257 T AT01959257 T AT 01959257T AT 01959257 T AT01959257 T AT 01959257T AT E504589 T1 ATE504589 T1 AT E504589T1
Authority
AT
Austria
Prior art keywords
aryl
alkyl
alkenyl
present
unsubstituted
Prior art date
Application number
AT01959257T
Other languages
German (de)
English (en)
Inventor
Michael Boyd
Kirk Gustafson
Charles Cantrell
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE504589T1 publication Critical patent/ATE504589T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/08—Bridged systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT01959257T 2000-07-24 2001-07-24 Biologisch aktive macrolide, ihre zusammensetzungen und anwendungen ATE504589T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22027000P 2000-07-24 2000-07-24
PCT/US2001/023633 WO2002008231A2 (en) 2000-07-24 2001-07-24 Biologically active macrolides, compositions, and uses thereof

Publications (1)

Publication Number Publication Date
ATE504589T1 true ATE504589T1 (de) 2011-04-15

Family

ID=22822844

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01959257T ATE504589T1 (de) 2000-07-24 2001-07-24 Biologisch aktive macrolide, ihre zusammensetzungen und anwendungen

Country Status (8)

Country Link
US (5) US7144918B2 (https=)
EP (1) EP1303522B1 (https=)
JP (1) JP4980542B2 (https=)
AT (1) ATE504589T1 (https=)
AU (2) AU2001280834B2 (https=)
CA (1) CA2415611C (https=)
DE (1) DE60144376D1 (https=)
WO (1) WO2002008231A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144376D1 (de) 2000-07-24 2011-05-19 Us Government N und anwendungen
AU2003269924B2 (en) 2002-07-24 2008-01-24 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Chondropsin-class antitumor V-ATPase inhibitor compounds, compositions and methods of use thereof
WO2010144611A2 (en) * 2009-06-10 2010-12-16 3-V Biosciences, Inc. Antivirals that target transporters, carriers, and ion channels

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2001510838A (ja) * 1997-07-25 2001-08-07 アメリカ合衆国 マクロサイクリックラクトン、組成物、および使用方法
US7381744B1 (en) * 1999-03-05 2008-06-03 The United States Of America As Represented By The Department Of Health And Human Services Method of treating osteoporosis comprising vacuolar-type (H+)-ATPase-inhibiting compounds
DE60144376D1 (de) * 2000-07-24 2011-05-19 Us Government N und anwendungen

Also Published As

Publication number Publication date
AU8083401A (en) 2002-02-05
CA2415611C (en) 2011-03-15
JP2004504399A (ja) 2004-02-12
US7144918B2 (en) 2006-12-05
CA2415611A1 (en) 2002-01-31
US20040087566A1 (en) 2004-05-06
US20060205707A1 (en) 2006-09-14
US9139595B2 (en) 2015-09-22
DE60144376D1 (de) 2011-05-19
WO2002008231A3 (en) 2002-06-27
US20140243284A1 (en) 2014-08-28
EP1303522B1 (en) 2011-04-06
US8741947B2 (en) 2014-06-03
WO2002008231A2 (en) 2002-01-31
US20150374661A1 (en) 2015-12-31
JP4980542B2 (ja) 2012-07-18
US9820965B2 (en) 2017-11-21
EP1303522A2 (en) 2003-04-23
AU2001280834B2 (en) 2006-08-10
US20100298248A1 (en) 2010-11-25
US7790764B2 (en) 2010-09-07

Similar Documents

Publication Publication Date Title
ATE176466T1 (de) Furyl-oder thienylcarbonyl-substituierte taxane und diese enthaltende arzneimittel
IL140093A0 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
BR9909961A (pt) Derivados de cadeia lateral alquila e alquenila funcionalizados de glicinamidas como inibidores de farnesil transferase
TWI262805B (en) Pharmaceutical composition for treating or inhibiting colonic polyps
NL350075I2 (https=)
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
ATE242634T1 (de) Benzimidazolderivaten-enthaltende pharmazeutische zusammensetzungen zur inhibierung des krebswachstums
DE69928567D1 (de) Biodegradierbare polyphosphoester-zusammensetzungen zur behandlung von ovarialkrebs
DE60215656D1 (de) Photostabile organische sonnenschutzmittel mit antioxidativen eigenschaften und zusammensetzungen damit
AR012032A1 (es) Compuestos derivados 3'-n-oxido, 3'-n-dimetilamina, 9-oxima eritromicina a y un proceso para su preparacion
CA2280905A1 (en) Highly lipophilic camptothecin derivatives
TR200103395T2 (tr) 13-metil eritromisin türevleri.
TR199801935T2 (xx) N�trofil elastaz inhibit�rleri olarak pirolopirolon t�revleri.
IL136359A (en) Dihydrobenzofuran substituted phthalazin-1-one derivatives and pharmaceutical compositions containing the same
CA2406685A1 (en) Oxadiazole derivatives having anticancer effects
DE60229054D1 (de) Synthese von zyklopentadien derivaten
FI930171A0 (fi) Piperidinfoereningar, framstaellning och anvaendning av dessa
AP9801377A0 (en) Tricyclic erythromycin derivatives.
ATE504589T1 (de) Biologisch aktive macrolide, ihre zusammensetzungen und anwendungen
BR9907172A (pt) Derivados de azatriciclo[3.3.1.1] decano e composições farmacêuticas contendo-os
NZ331618A (en) Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
WO2001083457A3 (en) Benzimidazole-2-carbamates and their use in cancer treatment
ATE218858T1 (de) C9 taxanderivate und diese enthaltende pharmazeutische zusammensetzungen
TR200000263T2 (tr) Alopesi için ilaç.
AP9901559A0 (en) Tricyclic 3-keto derivatives of 6-0-methylerythromycin.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties